Skip to content

Insider · CIK 0001405290

Pham Quang X

Reports to the SEC for 2 companies · PONTE VEDRA, FL

Transactions

46

Companies

2

Filings

9

CIK

0001405290

Forms 4 and 5

Insider transactions

46 trades
DateCompanyValue
2026-06-29CVKDCadrenal Therapeutics, Inc.S Sale−$22.4K
2026-06-26CVKDCadrenal Therapeutics, Inc.S Sale−$27.5K
2026-06-25CVKDCadrenal Therapeutics, Inc.S Sale−$6,381
2026-06-23CVKDCadrenal Therapeutics, Inc.S Sale−$7,286.4
2026-06-22CVKDCadrenal Therapeutics, Inc.S Sale−$32.5K
2026-06-17CVKDCadrenal Therapeutics, Inc.S Sale−$1,621.08
2026-06-16CVKDCadrenal Therapeutics, Inc.S Sale−$11.5K
2026-06-15CVKDCadrenal Therapeutics, Inc.S Sale−$13.1K
2026-06-12CVKDCadrenal Therapeutics, Inc.S Sale−$51.2K
2026-06-11CVKDCadrenal Therapeutics, Inc.S Sale−$6,023.44
2026-06-10CVKDCadrenal Therapeutics, Inc.S Sale−$14.7K
2026-06-09CVKDCadrenal Therapeutics, Inc.S Sale−$52.7K
2026-06-08CVKDCadrenal Therapeutics, Inc.S Sale−$25.8K
2026-06-05CVKDCadrenal Therapeutics, Inc.S Sale−$9,122.88
2026-06-04CVKDCadrenal Therapeutics, Inc.S Sale−$17.2K
2026-06-03CVKDCadrenal Therapeutics, Inc.S Sale−$9,895.98
2026-06-02CVKDCadrenal Therapeutics, Inc.S Sale−$1,556.54
2026-05-29CVKDCadrenal Therapeutics, Inc.S Sale−$1,518.03
2026-05-28CVKDCadrenal Therapeutics, Inc.S Sale−$14.7K
2026-05-22CVKDCadrenal Therapeutics, Inc.S Sale−$6,628.85
2026-05-12CVKDCadrenal Therapeutics, Inc.S Sale−$17.4K
2026-05-11CVKDCadrenal Therapeutics, Inc.S Sale−$37.3K
2025-10-27CVKDCadrenal Therapeutics, Inc.S Sale−$18.4K
2025-10-24CVKDCadrenal Therapeutics, Inc.S Sale−$15.8K
2025-10-13CVKDCadrenal Therapeutics, Inc.S Sale−$25.5K
2025-10-09CVKDCadrenal Therapeutics, Inc.S Sale−$25.2K
2025-10-02CVKDCadrenal Therapeutics, Inc.S Sale−$7,065
2025-10-01CVKDCadrenal Therapeutics, Inc.S Sale−$12.3K
2025-09-29CVKDCadrenal Therapeutics, Inc.S Sale−$5,870.19
2025-09-25CVKDCadrenal Therapeutics, Inc.S Sale−$95.7K
2025-09-24CVKDCadrenal Therapeutics, Inc.S Sale−$36.1K
2025-08-28CVKDCadrenal Therapeutics, Inc.S Sale−$16.7K
2025-08-27CVKDCadrenal Therapeutics, Inc.S Sale−$53.7K
2025-01-23CVKDCadrenal Therapeutics, Inc. · Stock OptionsA Award—
2025-01-23CVKDCadrenal Therapeutics, Inc. · Stock OptionsA Award—
2024-04-10CVKDCadrenal Therapeutics, Inc.G Gift—
2024-01-18CVKDCadrenal Therapeutics, Inc. · Stock OptionsA Award—
2023-10-23CVKDCadrenal Therapeutics, Inc.G Gift—
2023-09-05CVKDCadrenal Therapeutics, Inc.P Purchase+$18K
2023-09-05CVKDCadrenal Therapeutics, Inc.P Purchase+$18.2K
2023-09-01CVKDCadrenal Therapeutics, Inc.P Purchase+$18.6K
2023-09-01CVKDCadrenal Therapeutics, Inc.P Purchase+$9,318
2023-09-01CVKDCadrenal Therapeutics, Inc.P Purchase+$9,168
2023-09-01CVKDCadrenal Therapeutics, Inc.P Purchase+$8,433
2023-09-01CVKDCadrenal Therapeutics, Inc.P Purchase+$18.4K
2023-02-10CVKDCadrenal Therapeutics, Inc.A Award+$48.5K

Recent filings

9

Companies

2

Address

C/O CADRENAL THERAPEUTICS, INC. 822 A1A NORTH, SUITE 306

PONTE VEDRA, FL, 32082